MEDICE ARZNEIMITTEL PUETTER GMBH & CO KG has a total of 15 patent applications. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), Hong Kong and Australia. Its main competitors in its focus markets pharmaceuticals are HMFRA HUNGARY LTD LIABILITY COMPANY, TANGENT REPROFILING LTD and SHANGHAI YOUSEEN NEW MEDICINE.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Hong Kong | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | China | 1 | |
#6 | Russian Federation | 1 | |
#7 | Ukraine | 1 | |
#8 | United States | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Ammer Richard | 12 |
#2 | Puetter Sigurd | 7 |
#3 | Schmidbauer Michael | 7 |
#4 | Lang Florian | 2 |
#5 | Buss Uwe | 2 |
#6 | Richard Ammer | 1 |
#7 | Michael Schmidbauer | 1 |
#8 | Sigurd Puetter | 1 |
Publication | Filing date | Title |
---|---|---|
EP3492071A1 | Pharmaceutical composition comprising benzocaine with enhanced stability | |
EP3368078A1 | Nicotinamide for lowering phosphate levels in hyperphosphatemia | |
UA123054C2 | Composition having antiviral effect | |
US2016143948A1 | Anti-virally effective pharmaceutical composition | |
EP2194984A1 | Medicament for treating or preventing proteinuria |